Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) announced a quarterly dividend on Wednesday, November 13th,Wall Street Journal reports. Shareholders of record on Tuesday, December 31st will be paid a dividend of 0.42 per share on Wednesday, January 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 8.95%. The ex-dividend date is Tuesday, December 31st. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07.
Crescent Capital BDC has a payout ratio of 82.8% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings tumble. Equities analysts expect Crescent Capital BDC to earn $1.99 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 84.4%.
Crescent Capital BDC Trading Down 0.2 %
Shares of CCAP stock traded down $0.03 during trading hours on Wednesday, hitting $18.78. The company had a trading volume of 139,236 shares, compared to its average volume of 132,574. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.40 and a quick ratio of 1.40. The stock has a market capitalization of $695.99 million, a PE ratio of 7.37 and a beta of 0.81. The company’s fifty day moving average is $18.39 and its 200 day moving average is $18.40. Crescent Capital BDC has a fifty-two week low of $15.91 and a fifty-two week high of $19.63.
Analysts Set New Price Targets
CCAP has been the topic of several research reports. LADENBURG THALM/SH SH initiated coverage on Crescent Capital BDC in a research note on Monday, September 30th. They set a “buy” rating and a $20.00 target price on the stock. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 14th. Finally, Bank of America cut their target price on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research note on Thursday, August 15th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $19.00.
Check Out Our Latest Research Report on CCAP
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
See Also
- Five stocks we like better than Crescent Capital BDC
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Rocket Lab is the Right Stock for the Right Time
- ETF Screener: Uses and Step-by-Step Guide
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What is the Australian Securities Exchange (ASX)
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.